Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Most Accessed Articles

C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors

Volume: 21   Issue: 1
Pp: 2-20
Milad Ashrafizadeh, Ali Zarabi, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, Farid Hashemi, Salman Daneshi, Fardin Hashemi, Shima Tavakol, Reza Mohammadinejad, Masoud Najafi*, Namrata Dudha and Manoj Garg*
DOI: 10.2174/1568009620666201016121005

COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide promotion: free to download

Volume: 20   Issue: 6
Pp: 410-416
Ning-Ning Liu*, Jing-Cong Tan, Jingquan Li, Shenghui Li*, Yong Cai* and Hui Wang*
DOI: 10.2174/1568009620666200414151419

The Impacts of Non-coding RNAs and N6-Methyladenosine on Cancer: Past, Present and Future

Volume: 21   Issue: 5
Pp: 375-385
Zhaoyuan Xu, Guohua Ji, Ying Cui and Xiaobo Cui*
DOI: 10.2174/1568009621999210120193636

Effects of Iron Chelation in Osteosarcoma

Volume: 21   Issue: 5
Pp: 443-455
Maura Argenziano, Alessandra Di Paola, Chiara Tortora, Daniela Di Pinto, Elvira Pota, Martina Di Martino, Silverio Perrotta, Francesca Rossi* and Francesca Punzo
DOI: 10.2174/1568009620666201230090531

The Mad2-Binding Protein p31comet as a Potential Target for Human Cancer Therapy

Volume: 21   Issue: 5
Pp: 401-415
Ana C. Henriques, Patrícia M. A. Silva, Bruno Sarmento and Hassan Bousbaa*
DOI: 10.2174/1568009621666210129095726

Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues

Volume: 21   Issue: 5
Pp: 428-442
Karthikeyan Subbarayan, Kamatchi Ulagappan, Claudia Wickenhauser and Barbara Seliger*
DOI: 10.2174/1568009620666201207145019

CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling

Volume: 20   Issue: 2
Pp: 156-165
Fang Peng, Chuansheng Yang, Yanan Kong, Xiaojia Huang, Yanyu Chen, Yangfan Zhou, Xinhua Xie* and Peng Liu*
DOI: 10.2174/1568009619666191118113220

PROTACs: Promising Approaches for Epigenetic Strategies to Overcome Drug Resistance

Volume: 21   Issue: 4
Pp: 306-325
Sarah F. Giardina*, Elena Valdambrini, J. David Warren and Francis Barany
DOI: 10.2174/1568009621666210203110857

Re-Sensitizing Tumor Cells to Cancer Drugs with Epigenetic Regulators open access plus

Volume: 21   Issue: 4
Pp: 353-359
Stefanie Rauscher, Richard Greil and Roland Geisberger*
DOI: 10.2174/1568009620666210108102723

Clinical Outcomes and Safety of Patients Treated with NAb-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer: The NAPA Study

Volume: 20   Issue: 11
Pp: 887-895
Martina Catalano, Giandomenico Roviello*, Raffaele Conca, Alberto D’Angelo, Valeria Emma Palmieri, Benedetta Panella, Roberto Petrioli, Anna Ianza, Stefania Nobili, Enrico Mini and Monica Ramello
DOI: 10.2174/1568009620999200918122426

The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance

Volume: 21   Issue: 4
Pp: 326-352
Shaun Wood, Amber Willbanks and Jason X. Cheng*
DOI: 10.2174/1568009621666210127092828